Environmental health - lead image
Environmental health - lead image

© Norther wind farm off the coast of Belgium and the Netherlands provides renewable energy for our operations in both countries.

Environmental Health
Environmental Health
GRI
  • J&J19-12
    Products achieving EARTHWARDS recognition
  • 302-5
    Reductions in energy requirements of products and services
SASB
  • HC-MS-410a.1
    Discussion of process to assess and manage environmental and human health considerations associated with chemicals in products, and meet demand for sustainable products

Product Sustainability

Lifecycle assessment with EARTHWARDS

Since 2009, we have utilized our EARTHWARDS program to encourage the development of more sustainable products across seven impact areas. When a product achieves at least three significant improvements, a board of external experts determines if it warrants EARTHWARDS recognition. Our adherence to the EARTHWARDS methodology is audited annually by an external verification company.

26
new products achieved EARTHWARDS recognition in 2019
70 EARTHWARDS-recognized products* resulted in the following annual impact reductions** :
  • 1,500
    MT less material used
  • 40,000
    liters of water saved
  • 170
    MT of waste reduced
  • 39,300
    MT CO2e of GHG emissions avoided


    * Products recognized between 2009-2019; excludes products that are no longer EARTHWARDS-recognized due to discontinuations, divestitures or changes to the product.

    ** Savings are for products recognized through the end of 2019 ad are estimated based on nest available methodologies for each impact reduction area; select products are not included in savings estimation because of lack of detailed area.

We are committed to developing more sustainable products that contribute to a healthier planet. Our approach is based on science and a lifecycle accountability for product impacts—from discovery and design, raw material sourcing and manufacturing to product use and end of life. See also our Position on Sustainable Products and Packaging.

Examples of newly recognized EARTHWARDS products from 2019 include:

LISTERINE Mouthwash Concentrated Formulas: We developed a concentrated premix of our LISTERINE Mouthwash formulas that are sent to local markets to create finished product. Prior to this change, finished products were shipped directly from one facility in a region to the final destination (for example, from Thailand to Japan or from Italy to Russia). Today, we ship a concentrated product that is diluted and finished in facilities closer to the end markets in North Asia and Russia. These changes eliminated more than 60% of greenhouse gas (GHG) emissions from transportation. At the same time, we were able to lightweight packaging, reducing plastic usage by 11%.

LE PETIT MARSEILLAIS Shower Gel Concentrates: We launched our first concentrated body cleansing gels in six sensory variants. With its breakthrough environmental- friendly formula achieving 98% biodegradability, the product range offers consumers the same number of showers from an optimized 100 mL bottle as they would get from a conventional 400 mL plastic one. Each bottle of LE PETIT MARSEILLAIS Mon Gel Douche Concentré is recyclable, uses 60% less plastic and requires 40% less water, benefiting both consumers and the environment.

DePuy Synthes Spine SYMPHONY: The SYMPHONY OCT System was designed to optimize and improve the instrumentation for posterior cervical fusion (PCF) to address the current procedural challenges of aging population, more complex cases, and the increasing cost of PCF.

The modular case and tray system allow for a large selection of implants and instruments to be brought into the operating room without the need for additional cases. This may result in the following savings:17 21% less container material to meet patient need; 34% reduction in blue wrap required; and 34% less energy and water used in sterilization/disinfection of instruments.

STELARA (ustekinumab) and SIMPONI (golimumab): Early in 2019, the Johnson & Johnson EARTHWARDS Board recognized STELARA and SIMPONI as EARTHWARDS products and reconfirmed all dosing forms of these two products.

The recognition of both products is based on their reduced dosing frequency, as compared to competing products18 that are addressing the same indication(s), which is resulting in a reduced environmental footprint.

A cross-functional team assessed the footprint, which resulted in demonstrated, relevant reductions in the use of raw materials, packaging and energy required for manufacturing as well as in the amount of waste that originates from using these products.

2020 Goal Progress
New and existing products representing 22% of Johnson & Johnson revenue achieved EARTHWARDS recognition.

Green chemistry

Lifecycle assessments of our chemically synthesized active pharmaceutical ingredients (APIs) usually indicate that their environmental footprint is most driven by sourced starting materials, building blocks, reagents and solvents.19

While we continue to integrate principles of green chemistry and engineering into our product development practices, to promote green chemistry and advance environmental sustainability with the API suppliers, the Janssen Pharmaceutical Companies of Johnson & Johnson also developed a Supplier Sustainability Roadmap to collaborate with suppliers and drive improvement.

In 2019, we worked with our suppliers involved in the extended supply chain of canagliflozin and darunavir to improve their synthesis processes by introducing the principle of product mass intensity (PMI) and shared best practice tools and resources used by the members of the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable. By doing so, our suppliers could target the process steps that contribute largely to the environmental footprint, and objectively measure the impacts of any process improvements they made. This has led to a significant improvement of our suppliers’ PMIs and has reduced process waste and related management costs while reducing the environmental impact of our products.

17 Adaptiv #103669830

18 STELARA as compared to ENBRELTM and HUMIRATM. SIMPONI as compared to REMICADE, ENBRELTM and HUMIRATM.

19 Geert Van Der Vorst et al., "Green Chemistry," February 2013,15, 744 – 748.

You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.
Continue